MSCs from Amniotic Membrane for COPD & Lung Disease

How Stem Plus applies MSCs from Amniotic Membrane within a personalised COPD & Lung Disease protocol — in the EU, from €3,000–€8,000.

For COPD & Lung Disease, MSCs from Amniotic Membrane are selected for their specific regenerative profile and delivered under GMP conditions. The protocol combines cell type, dose and delivery route to match your individual assessment.

This is one of several cell options for COPD & Lung Disease. Compare them on the COPD & Lung Disease overview, or see the MSCs from Amniotic Membrane page.

GMP-certified MSCs from Amniotic Membrane, characterised and viability-tested
Physician-led COPD & Lung Disease protocol
Transparent €3,000–€8,000 pricing
Remote follow-up worldwide

Educational information; investigational for several conditions. Outcomes vary.

Клеточная терапия уровня ЕС — без западноевропейских цен.

GMP-сертифицированная регенеративная медицина в сердце ЕС — от €3 000–8 000, доля от цен США или Германии. Индивидуальные протоколы для пациентов из 50+ стран.

Бесплатная оценка врача

MSCs from Amniotic Membrane for COPD & Lung Disease

Related

Клеточная терапия уровня ЕС — без западноевропейских цен.